The respiratory segment, often influenced by seasonal factors, registered a 1.1% increase in value but faced a 4.6% decline ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

James Irvine, the manager of the pharmacy on Palm and Bullard Avenue, says they've seen a lot of people coming in to pick up medications that help treat respiratory illnesses, like the flu. "We've ...

Among them, the cardiac, gastrointestinal, and antidiabetic therapies saw high value growth of 9.5 per cent, 9.6 per cent, ...

The Indian QR coding programme meant to protect domestic drug supplies has failed, and is now a gift to the counterfeiters.

For further results highlights, click. GlaxoSmithKline Pharma has been benefitting from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Strong demand for ...

Drug prices have remained high as the federal government's plan to introduce zero tariffs on pharmaceutical products drags.

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

Augmentin, a combination of amoxicillin and clavulanate potassium, maintained its top-selling brand status in the Indian pharmaceutical market, selling around Rs 75-80 crore per month. The strong ...

Flagship brands within the general medicines portfolio, including Augmentin, Ceftum, and T-Bact, strengthened their market positions with share gains. The company’s innovative respiratory ...

Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...